# Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC

> **NIH NIH OT2** · FOUNDATION FOR THE NIH · 2024 · $3,255,169

## Abstract

RECOVER-TLC
 Abstract for FNIH OT Proposal
Establishment of a Public Private Partnership (PPP) to Support RECOVER-TLC
 September 18, 2024
The NIH will collaborate with the FNIH to create a long COVID-19 public-private partnership (PPP) to
accelerate the development of therapeutics, consistent with the FNIH’s own mission and the
Congressional statute by which the FNIH was established to support the NIH in its mission and to
advance collaboration with biomedical researchers from universities, industry, nonprofit organizations,
and other federal agencies, including the US Food and Drug Administration (FDA). The overarching goal
of the FNIH in this new PPP is to support the NIH in designing and implementing a strategic and
coordinated cross-sector approach to address the current long COVID challenges and lack of effective
therapies. This PPP is now known as RECOVER-TLC, the NIH Researching COVID to Enhance Recovery-
Treating Long COVID (RECOVER-TLC).

## Key facts

- **NIH application ID:** 11194672
- **Project number:** 1OT2OD039735-01
- **Recipient organization:** FOUNDATION FOR THE NIH
- **Principal Investigator:** Meghan Pennini
- **Activity code:** OT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,255,169
- **Award type:** 1
- **Project period:** 2024-09-25 → 2026-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11194672

## Citation

> US National Institutes of Health, RePORTER application 11194672, Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC (1OT2OD039735-01). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/11194672. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*